Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Debt Ratio (2020)

Updated

Anebulo Pharmaceuticals' Debt Ratio was 0.07 in fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Anebulo Pharmaceuticals (ANEB) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 0.07
API Access

Anebulo Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ANEB&period=max&api_key=YOUR_API_KEY